The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Expression of the Epstein–Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
Open accessAbstract
The latent membrane protein 1 (LMP1) of the Epstein–Barr virus has transforming properties in rodent fibroblasts and is expressed in most of the cancers associated with Epstein–Barr virus (EBV) infection including posttransplant lymphomas, Hodgkin’s disease, nasopharyngeal carcinoma, and AIDS-related lymphomas. In this study, three lineages of LMP1 transgenic mice were established with LMP1 expressed under the control of the Ig heavy chain promoter and enhancer. Lymphoma developed in all three lineages, and the incidence of lymphoma increased significantly with age with lymphomas developing in 42% of transgenic mice over 18 months. The expression of LMP1 was detected at high levels in the lymphoma tissues but only at trace levels in normal lymphoid tissues. Gene rearrangement of the Ig heavy chain indicated monoclonality or oligoclonality in all lymphomas, some of the lymphoid hyperplastic spleens, and some histologically normal spleens. These data reveal that LMP1, without the expression of other EBV genes, is oncogenic in vivo and indicate that LMP1 is a major contributing factor to the development of EBV-associated lymphomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Mosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
Raab-Traub, N., & Flynn, K. (1986) · Cell · doi:10.1016/0092-8674(86)90803-2 · Cited by 912
Self-citationNovel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
McDonnell, T. J., & Korsmeyer, S. J. (1991) · Nature · doi:10.1038/349254a0 · Cited by 858
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Kilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
Latent membrane protein 1of Epstein-Barr virus mimics a constitutively active receptor molecule
Gires, O. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6131 · Cited by 451
Involvement of CRAF1, a relative of TRAF, in CD40 signaling
Cheng, G., Cleary, A. M., Ye, Z.-S., Hong, D. I., Lederman, S., & Baltimore, D. (1995) · Science · doi:10.1126/science.7533327 · Cited by 449
Song, H. Y., Rothe, M., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6721 · Cited by 414
Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35741-7 · Cited by 409
Grossman, S. R., Johannsen, E., Tong, X., Yalamanchili, R., & Kieff, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7568 · Cited by 345
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
Masking of the CBF1/RBPJ κ Transcriptional Repression Domain by Epstein-Barr Virus EBNA2
Hsieh, J. J.-D., & Hayward, S. D. (1995) · Science · doi:10.1126/science.7725102 · Cited by 293
Frykberg, L., Palmieri, S., Beug, H., Graf, T., Hayman, M. J., & Vennström, B. (1983) · Cell · doi:10.1016/0092-8674(83)90513-5 · Cited by 287
Transgenic Models of Tumor Development
Adams, J. M., & Cory, S. (1991) · Science · doi:10.1126/science.1957168 · Cited by 280
Fries, K. L., Miller, W. E., & Raab-Traub, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8653-8659.1996 · Cited by 255
Self-citationWilson, J. B., Weinberg, W. C., Johnson, R., Yuspa, S. H., & Levine, A. J. (1990) · Cell · doi:10.1016/0092-8674(90)90695-b · Cited by 247
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
Hennessy, K., Fennewald, S. M., Hummel, M., Cole, T. J., & Kieff, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7207 · Cited by 220
Izumi, K. M., Kaye, K. M., & Kieff, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1447 · Cited by 218
Hammarskjöld, M. L., & Simurda, M. C. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6496-6501.1992 · Cited by 206
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5602-5612.1994 · Cited by 200
Miller, W. E., Mosialos, G., Kieff, E., & Raab-Traub, N. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.586-594.1997 · Cited by 167
Self-citationWang, S., Rowe, M., & Lundgren, E. (1996) · PubMed · Cited by 162
Hammerschmidt, W., Sugden, B., & Baichwal, V. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2469-2475.1989 · Cited by 151
Hatzivassiliou, E., Miller, W. E., Raab‐Traub, N., Kieff, E. D., & Mosialos, G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1116 · Cited by 123
Self-citationHatzivassiliou, E., Miller, W. E., Raab‐Traub, N., Kieff, E. D., & Mosialos, G. (1998) · PubMed · Cited by 115
Self-citationMcCarthy, S. A., Symonds, H., & Dyke, T. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3979 · Cited by 104
Paine, E., Scheinman, R. I., Baldwin, A. S., & Raab‐Traub, N. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4572-4576.1995 · Cited by 103
Self-citationSchauer, S. L., Wang, Z., Sonenshein, G. E., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.81 · Cited by 96
Cited by
Cohen, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430707 · Cited by 1,636
The biology of Hodgkin's lymphoma
Küppers, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2542 · Cited by 688
B cells under influence: transformation of B cells by Epstein–Barr virus
Küppers, R. (2003) · Nature Reviews Immunology · doi:10.1038/nri1201 · Cited by 529
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
Kutok, J. L., & Wang, F. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100209 · Cited by 493
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Münz, C. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0249-7 · Cited by 469
Metadata
- Authors
- Kulwichit, W., Edwards, R. H., Davenport, E. M., Baskar, J. F., Godfrey, V., & Raab-Traub, N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-09-29
- Volume
- 95
- Issue
- 20
- Pages
- 11963-11968
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2138241311
- Cited by
- 414
- References
- 35
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.